Haemolytic-uraemic Syndrome Caused by Vero Toxin-producing Escherichia coli Serotype Rough: K^-: H49

By Keskimäki Markku   Ratiner Yuli   Oinonen Sinikka   Leijala Esko   Nurminen Marjatta   Saari Marjut   Siitonen Anja  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 2, 1999-07 ,pp. : 141-144

Informa Healthcare

Access to resources Recommend Favorite

Haemolytic Uraemic Syndrome

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c37-c42

Karger

Access to resources Recommend Favorite

Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 118-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 306-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1054-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite